Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_assertion type Assertion NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_head.
- NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_assertion description "[The best time point to determine cure of chronic hepatitis C was explored in a retrospective analysis of five published trials of sofosbuvir?ribavirin with or without PEG-IFN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_provenance.
- NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_assertion evidence source_evidence_literature NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_provenance.
- NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_assertion SIO_000772 25421584 NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_provenance.
- NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_assertion wasDerivedFrom befree-2016 NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_provenance.
- NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_assertion wasGeneratedBy ECO_0000203 NP1239673.RAegwPIoxP2uLucwOBDBTYgWW2gc-0yI1K9YFzb0PlfxA130_provenance.